IMPROVED OUTCOME OVER TIME AFTER SECOND ALLOGENEIC STEM CELL TRANSPLANTATION IN RELAPSED AML. AN ANALYSIS OF 1540 PATIENTS ON BEHALF OF THE ALWP OF EBMT

被引：0
|
作者：
Schmaelter, Ann-Kristin [1 ]
Ngoya, Maud [2 ]
Galimard, Jacques-Emmanuel [2 ]
Bazarbachi, Ali [3 ]
Finke, Juergen [4 ]
Kroeger, Nicolaus [5 ]
Stoelzel, Friedrich [6 ]
Stelljes, Matthias [7 ]
Valerius, Thomas [8 ]
Tischer, Johanna [9 ]
Schroeder, Thomas [10 ]
Dreger, Peter [11 ]
Blau, Igor-Wolfgang [12 ]
Savani, Bipin [13 ]
Giebel, Sebastian [14 ]
Esteve, Jordi [15 ]
Nagler, Arnon [16 ]
Schmid, Christoph [1 ]
Ciceri, Fabio [17 ]
Mohty, Mohamad [2 ,18 ]
机构：
[1] Univ Hosp Augsburg, Augsburg, Germany
[2] EBMT Paris Study Off, Paris, France
[3] Amer Univ, Beirut Med Ctr, Beirut, Lebanon
[4] Univ Freiburg, Freiburg, Germany
[5] Univ Med Ctr Hamburg Eppendorf, Hamburg, Germany
[6] Univ Hosp Dresden, Dresden, Germany
[7] Univ Munster, Munster, Germany
[8] Univ Med Ctr Schleswig Holstein, Kiel, Germany
[9] Univ Hosp Munich, Munich, Germany
[10] Univ Hosp Essen, Essen, Germany
[11] Heidelberg Univ, Heidelberg, Germany
[12] Charite Univ Med Berlin, Berlin, Germany
[13] Vanderbilt Univ, Med Ctr, Nashville, TN USA
[14] Maria Sklodowska Curie Canc Ctr & Inst Oncol, Gliwice, Poland
[15] Hosp Clin Barcelona, Barcelona, Spain
[16] Tel Aviv Univ, Chaim Sheba Med Ctr, Tel Aviv, Israel
[17] Univ Vita Salute San Raffaele, IRCCS Osped San Raffaele, Milan, Italy
[18] St Antoine Hosp, Paris, France
来源：
BONE MARROW TRANSPLANTATION | 2023年 / 58卷 / SUPP1期
关键词：
D O I：
暂无
中图分类号：
Q6 [生物物理学];
学科分类号：
071011 ;
摘要：
P275
引用
收藏
页码：341 / 342
页数：2
相关论文
共 50 条
  • [41] The Impact of Cytogenetics on the Outcome of Allogeneic Hematopoietic Stem Cell Transplantation in Patients with Relapsed/Refractory Acute Myeloid Leukemia: A Survey from the Acute Leukemia Working Party (ALWP) of EBMT
    Poiani, Monica
    Labopin, Myriam
    Beelen, Dietrich W.
    Tischer, Johanna
    Finke, Juergen
    Brecht, Arne
    Forcade, Edouard
    Ganser, Arnold
    Passweg, Jakob R.
    Labussiere-Wallet, Helene
    Yakoub-Agha, Ibrahim
    Schaefer-Eckart, Kerstin
    Kroeger, Nicolaus
    Lioure, Bruno
    Ruggeri, Annalisa
    Esteve, Jordi
    Nagler, Arnon
    Mohty, Mohamad
    BLOOD, 2018, 132
  • [42] CHEMOTHERAPY DOSE ADJUSTMENT FOR OBESE PATIENTS UNDERGOING HEMATOPOIETIC STEM CELL TRANSPLANTATION (HSCT): A SURVEY ON BEHALF OF THE ALWP OF THE EBMT
    Shem-Tov, N.
    Labopin, M.
    Moukhtari, L.
    Ciceri, F.
    Esteve, J.
    Giebel, S.
    Gorin, N. -C.
    Schmid, C.
    Shimoni, A.
    Nagler, A.
    Mohty, M.
    BONE MARROW TRANSPLANTATION, 2014, 49 : S40 - S40
  • [43] Second allogeneic stem cell transplantation as salvage of relapsed haematologic malignancies after stem cell transplantation
    Tan, T.
    Wu, M.
    BONE MARROW TRANSPLANTATION, 2013, 48 : S258 - S259
  • [44] Outcome after allogeneic transplantation for adult acute myeloid leukemia patients exhibiting isolated or associated trisomy 8 chromosomal abnormality: a survey on behalf of the ALWP of the EBMT
    Chevallier, P.
    Labopin, M.
    Nagler, A.
    Ljungman, P.
    Verdonck, L. F.
    Volin, L.
    Zander, A. R.
    Finke, J.
    Socie, G.
    Cordonnier, C.
    Harousseau, J-L
    Mohty, M.
    Rocha, V.
    BONE MARROW TRANSPLANTATION, 2009, 44 (09) : 589 - 594
  • [45] Adoptive immunotherapy ± Ruxolitinib and second allogeneic hematopoietic stem cell transplantation in patients with relapsed Myelofibrosis after allogeneic hematopoietic stem cell transplantation
    Bogdanov, R.
    Ditschkowski, M.
    Steckel, N. -K.
    Klisanin, V.
    Kordelas, L.
    Trenschel, R.
    Beelen, D. W.
    ONCOLOGY RESEARCH AND TREATMENT, 2018, 41 : 60 - 61
  • [46] Outcome after allogeneic transplantation for adult acute myeloid leukemia patients exhibiting isolated or associated trisomy 8 chromosomal abnormality: a survey on behalf of the ALWP of the EBMT
    P Chevallier
    M Labopin
    A Nagler
    P Ljungman
    L F Verdonck
    L Volin
    A R Zander
    J Finke
    G Socie
    C Cordonnier
    J-L Harousseau
    M Mohty
    V Rocha
    Bone Marrow Transplantation, 2009, 44 : 589 - 594
  • [47] Outcome after Allogeneic Stem Cell Transplantation for Adult Acute Myeloid Leukaemia Patients Exhibiting Isolated or Associated Trisomy 8 Chromosomal Abnormality: A Survey on Behalf of the Acute Leukemia Working Party (ALWP) of the EBMT
    Chevallier, Patrice
    Labopin, Myriam
    Nagler, Arnon
    Ljungman, Per T.
    Verdonck, Leo
    Volin, Liisa
    Zander, Axel
    Finke, Juergen
    Socie, Gerard
    Cordonnier, Catherine
    Harousseau, Jean-Luc
    Mohty, Mohamad
    Rocha, Vanderson
    BLOOD, 2008, 112 (11) : 412 - 412
  • [48] Encouraging Outcome of AML with t(8;16) Following Allogeneic Stem Cell Transplantation in First Remission - a Retrospective Analysis on Behalf of the Acute Leukemia Working Party of the EBMT
    Schmaelter, Ann-Kristin
    Labopin, Myriam
    Versluis, Jurjen
    Hernanz, Maria Pilar Gallego
    Eder, Matthias
    Borne, Peter A. Von Dem
    Socie, Gerard
    Chevallier, Patrice
    Forcade, Edouard
    Neubauer, Andreas
    Baron, Frederic
    Bazarbachi, Ali
    Bug, Gesine
    Nagler, Arnon
    Schmid, Christoph
    Esteve, Jordi
    Ciceri, Fabio
    Mohty, Mohamad
    BLOOD, 2023, 142
  • [49] PD-1 checkpoint blockade in patients with relapsed AML after allogeneic stem cell transplantation
    J C Albring
    S Inselmann
    T Sauer
    C Schliemann
    B Altvater
    S Kailayangiri
    C Rössig
    W Hartmann
    J R Knorrenschild
    K Sohlbach
    C Groth
    M Lohoff
    A Neubauer
    W E Berdel
    A Burchert
    M Stelljes
    Bone Marrow Transplantation, 2017, 52 : 317 - 320
  • [50] PD-1 checkpoint blockade in patients with relapsed AML after allogeneic stem cell transplantation
    Albring, J. C.
    Inselmann, S.
    Sauer, T.
    Schliemann, C.
    Altvater, B.
    Kailayangiri, S.
    Roessig, C.
    Hartmann, W.
    Knorrenschild, J. R.
    Sohlbach, K.
    Groth, C.
    Lohoff, M.
    Neubauer, A.
    Berdel, W. E.
    Burchert, A.
    Stelljes, M.
    BONE MARROW TRANSPLANTATION, 2017, 52 (02) : 317 - 320
12345